TSS:Hg 147640.1

Basic information about the TSS

---

TSS ID: hg_147640.1 Species: human Chr: chr15		Start: 73994668 End: 73994677 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000395135.7 NM_033247 NM_033250 NM_033249 NM_033238 NM_033246 NM_033244 NM_033240 NM_002675 NM_033239 uc002awr.4 X63131 Distance: 0 GeneID: 5371 HGNC/MGI_ID: HGNC:9113 UniProt_ID: P29590

Gene_name: promyelocytic leukemia Gene_symbol: PML Gene_synonyms: MYL RNF71 TRIM19 Gene_source: HGNC:9113

TATA-Box annotation

---

Distance to TSS:	0
Nearest PromoterID:	NM_033246
Entrez ID:	5371
Nearest Unigene:	Hs.526464
Nearest Refseq:	NM_002675
Nearest Ensembl:	ENSG00000140464
Gene Name:	promyelocytic leukemia
Gene Alias:	MYL
Gene Description:	promyelocytic leukemia
Gene Type:	protein-coding
CpG%:	0.05
GC%:	0.631841
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):	"-63(TCTTTAAAACCC,+,0.00)"

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PML p2@PML p3@PML
Sample		p1@PML	p2@PML	p3@PML
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	30.78	0.78	0.78
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	32.17	2.02	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	31.25	2.51	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	32.23	2.08	0.83
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	29.47	1.80	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	29.46	1.36	1.55
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	44.45	3.92	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	40.69	2.91	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	38.68	3.21	1.28
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	57.38	11.59	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	55.78	8.89	1.62
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	61.80	5.69	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	92.20	6.93	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	69.16	6.62	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	84.97	7.03	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	89.78	9.31	1.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	86.49	5.90	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	80.15	7.17	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	116.76	2.67	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	75.97	6.02	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	89.81	5.48	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	80.44	6.04	0.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	89.96	8.14	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	90.03	5.10	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	110.16	10.84	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	104.13	8.23	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	115.94	6.04	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	121.88	16.97	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	109.19	9.69	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	112.20	13.57	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	120.58	14.24	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	121.53	15.83	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	138.22	16.67	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	136.41	16.33	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	117.06	20.94	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	124.17	19.74	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	119.36	21.46	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	128.35	22.37	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	132.89	25.66	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	120.99	23.05	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	124.69	21.17	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	137.03	21.52	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	124.22	30.58	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	146.85	30.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	126.49	31.92	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	138.42	29.08	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	143.46	28.07	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	148.73	28.61	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	140.27	33.51	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	148.01	26.89	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	158.63	35.87	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	167.23	26.91	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	251.86	83.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	117.10	22.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	106.04	21.21	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	230.71	52.85	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	146.50	28.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	116.68	25.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	101.49	17.66	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	181.05	24.20	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	80.38	16.92	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	84.68	15.14	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	496.79	71.65	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	193.67	16.65	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	143.29	22.42	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	111.11	16.33	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	193.97	113.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	157.95	165.85	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	91.65	14.63	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	80.83	7.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	82.09	12.20	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	192.09	21.86	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	91.57	12.68	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	106.40	17.73	1.22
Adipocyte - breast, donor1	11376-118A8	44.82	5.07	0.32
Adipocyte - breast, donor2	11327-117E4	56.95	5.29	0.16
Adipocyte - omental, donor1	11473-119C6	62.09	6.62	0.51
Adipocyte - omental, donor2	11474-119C7	58.30	2.24	0.00
Adipocyte - omental, donor3	11475-119C8	52.92	3.01	0.00
Adipocyte - perirenal, donor1	11476-119C9	56.14	2.55	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	31.89	5.50	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	61.42	8.13	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	62.73	4.87	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	58.67	11.34	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	97.55	14.16	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	86.70	15.33	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	106.98	18.22	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	35.87	7.48	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	113.61	21.95	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	47.45	7.46	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	59.54	3.34	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	36.60	5.41	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	56.01	15.07	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	36.00	4.58	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	32.58	3.35	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	50.83	4.42	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	119.41	6.45	1.08
Alveolar Epithelial Cells, donor3	11671-122G6	52.71	7.19	2.40
Amniotic Epithelial Cells, donor1	11533-120A3	27.89	1.44	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	43.51	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	52.18	1.64	0.21
Anulus Pulposus Cell, donor1	11248-116E6	57.10	5.03	0.23
Anulus Pulposus Cell, donor2	11463-119B5	79.11	4.16	1.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	75.93	6.29	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	86.83	6.95	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	81.33	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	76.82	8.97	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	82.20	3.79	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	47.53	3.30	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	71.15	6.82	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	63.11	8.25	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	62.36	5.34	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	67.79	4.90	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	75.47	4.35	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	46.39	5.02	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	51.23	5.77	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	70.97	8.19	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	30.31	4.67	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	74.47	9.11	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	63.48	7.75	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	66.29	6.68	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	82.91	6.83	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	57.72	6.14	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	68.44	2.40	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	74.34	7.08	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	65.01	8.40	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	75.51	12.58	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	63.11	4.85	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	70.20	4.93	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	52.09	8.48	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	62.70	11.40	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	62.64	5.13	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	57.04	6.45	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	76.95	7.04	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	62.70	7.07	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	54.22	4.28	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	73.12	5.85	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	61.12	7.23	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	47.52	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	81.37	8.14	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	63.93	7.64	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	50.19	2.54	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	80.27	8.63	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	63.51	6.77	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	58.00	5.22	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	91.64	8.50	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	52.72	6.61	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	67.17	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	103.52	19.01	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	73.76	9.22	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	91.45	8.42	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	78.73	8.02	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	87.58	11.26	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	79.06	12.75	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	46.52	5.34	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	84.43	12.59	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	71.60	15.30	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	93.21	8.13	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	73.40	10.64	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	61.03	6.10	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	64.25	9.42	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	62.49	10.33	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	65.06	6.18	0.36
Astrocyte - cerebellum, donor1	11500-119F6	131.05	13.76	1.47
Astrocyte - cerebellum, donor2	11580-120F5	141.55	12.15	2.05
Astrocyte - cerebellum, donor3	11661-122F5	79.70	11.54	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	44.27	6.27	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	101.76	15.04	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	52.36	9.84	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	107.35	27.87	1.61
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	94.21	25.81	1.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	102.76	26.97	0.68
Basophils, donor1	12241-129G9	34.00	22.49	0.00
Basophils, donor2	12242-129H1	45.82	20.57	0.36
Basophils, donor3	12243-129H2	22.78	10.44	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	51.31	1.08	1.08
Bronchial Epithelial Cell, donor2	11591-120G7	174.19	5.03	1.37
Bronchial Epithelial Cell, donor3	11672-122G7	43.04	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	82.85	5.02	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	119.57	3.74	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	49.28	0.69	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	39.23	0.36	0.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	37.92	4.43	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	35.40	8.85	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	54.36	15.03	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	62.05	31.03	0.00
CD14+ Monocytes, donor1	11224-116B9	26.49	18.60	0.56
CD14+ Monocytes, donor2	11305-117B9	41.57	23.20	0.37
CD14+ Monocytes, donor3	11381-118B4	41.27	19.10	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	44.72	12.17	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	46.25	7.20	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	57.53	12.49	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	25.30	13.59	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	24.74	10.56	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	34.82	20.37	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	22.93	11.38	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	20.42	10.76	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	25.29	13.64	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	208.92	89.87	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	164.52	92.23	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	181.29	77.91	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	37.23	16.86	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	36.96	21.12	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	23.30	14.42	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	22.76	8.63	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	14.97	7.98	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	17.07	6.87	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	103.87	61.31	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	51.80	26.69	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	77.25	42.34	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	240.48	109.48	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	195.74	109.21	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	262.17	135.93	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	143.11	71.46	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	83.49	34.87	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	129.42	66.25	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	177.86	83.53	0.87
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	145.33	76.57	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	178.47	84.50	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	196.55	102.37	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	94.11	49.14	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	151.26	71.69	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	29.64	15.91	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	26.56	13.17	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	25.34	14.95	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	48.59	19.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	32.13	14.32	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	65.78	28.32	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	32.92	10.72	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	38.86	17.13	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	35.37	18.95	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	58.94	10.16	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	53.56	15.59	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	68.35	13.46	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	43.18	15.99	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	61.11	16.62	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	57.56	14.04	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	59.61	11.77	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	43.50	10.55	0.00
CD19+ B Cells, donor1	11544-120B5	86.30	25.48	0.82
CD19+ B Cells, donor2	11624-122B4	60.94	20.31	0.00
CD19+ B Cells, donor3	11705-123B4	76.73	13.13	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	69.50	12.12	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	48.74	11.98	0.40
CD34+ Progenitors, donor1	11545-120B6	34.14	10.04	1.00
CD34+ Progenitors, donor2	11625-122B5	57.30	29.21	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	68.39	13.53	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	63.14	20.52	1.35
CD4+ T Cells, donor1	11225-116C1	65.34	14.28	2.14
CD4+ T Cells, donor2	11306-117C1	69.20	11.63	1.22
CD4+ T Cells, donor3	11382-118B5	55.81	11.59	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	74.02	14.55	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	79.51	13.93	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	87.68	15.81	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	49.78	3.32	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	50.57	5.62	1.40
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	75.81	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	82.23	9.97	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	75.75	15.08	0.85
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	67.22	15.48	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	52.00	7.17	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	55.55	8.04	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	79.64	14.52	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	75.05	9.70	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	75.21	22.65	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	63.82	12.36	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	87.02	7.89	2.18
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	93.26	6.43	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	104.01	8.97	3.59
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	95.50	14.46	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	71.05	13.86	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	76.50	15.76	0.42
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	53.09	10.11	1.01
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	44.19	10.83	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	89.78	13.95	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	71.76	12.87	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	54.47	11.08	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	55.83	6.98	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	75.05	8.31	1.11
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	86.62	9.08	1.23
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	67.76	9.24	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	81.65	11.46	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	40.16	13.85	0.00
CD8+ T Cells, donor1	11226-116C2	51.40	16.04	0.33
CD8+ T Cells, donor2	11307-117C2	64.20	27.78	0.38
CD8+ T Cells, donor3	11383-118B6	54.79	17.93	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	25.69	3.90	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	23.25	3.59	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	26.26	3.56	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	29.42	2.70	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	31.44	3.84	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	27.97	4.32	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	28.25	7.39	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	30.79	3.95	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	31.89	4.46	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	30.79	6.94	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	30.21	4.36	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	32.77	3.73	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	36.77	6.57	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	46.00	5.47	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	56.69	8.95	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	27.73	2.88	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	25.89	2.88	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	25.69	4.71	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	33.27	6.34	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	27.99	7.38	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	24.04	4.81	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	29.45	5.35	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	24.04	3.94	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	27.23	5.29	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	41.75	3.21	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	55.25	2.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	39.07	8.01	2.00
Cardiac Myocyte, donor1	11525-119I4	186.43	38.38	0.00
Cardiac Myocyte, donor2	11605-120I3	88.94	10.87	0.99
Cardiac Myocyte, donor3	11686-122I3	40.94	4.74	0.21
Chondrocyte - de diff, donor1	11261-116G1	29.81	1.73	0.00
Chondrocyte - de diff, donor2	11338-117F6	31.98	4.26	0.36
Chondrocyte - de diff, donor3	11410-118E6	30.38	3.75	0.11
Chondrocyte - re diff, donor2	11339-117F7	37.60	3.58	0.90
Chondrocyte - re diff, donor3	11411-118E7	65.11	4.04	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	98.69	18.94	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	70.54	9.19	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	78.23	12.12	0.71
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	57.50	21.55	1.01
Corneal Epithelial Cells, donor1	11526-119I5	86.07	5.05	1.54
Corneal Epithelial Cells, donor2	11606-120I4	100.11	3.41	1.14
Corneal Epithelial Cells, donor3	11687-122I4	77.71	4.60	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	39.29	9.41	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	35.96	7.89	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	24.15	17.25	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	33.69	11.88	0.54
Dendritic Cells - plasmacytoid, donor1	11228-116C4	21.52	4.44	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	28.73	7.83	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	28.55	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	77.55	9.84	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	88.02	10.56	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	113.12	9.05	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	112.45	14.55	0.39
Endothelial Cells - Artery, donor1	11264-116G4	100.06	13.96	0.29
Endothelial Cells - Artery, donor2	11341-117F9	86.35	11.06	0.00
Endothelial Cells - Artery, donor3	11413-118E9	121.66	17.53	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	76.91	9.09	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	93.41	13.08	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	98.67	12.97	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	137.28	8.62	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	101.53	13.54	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	170.14	18.57	0.57
Endothelial Cells - Thoracic, donor1	11266-116G6	86.43	4.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	83.86	12.58	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	111.20	14.16	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	107.33	11.30	0.65
Endothelial Cells - Umbilical vein, donor3	11400-118D5	108.08	12.58	1.10
Endothelial Cells - Vein, donor1	11267-116G7	98.96	13.65	0.00
Endothelial Cells - Vein, donor2	11344-117G3	113.16	17.46	0.00
Endothelial Cells - Vein, donor3	11416-118F3	70.50	6.75	0.16
Eosinophils, donor1	12244-129H3	45.74	15.25	0.00
Eosinophils, donor2	12245-129H4	77.56	62.71	0.00
Eosinophils, donor3	12246-129H5	121.27	71.34	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	55.46	1.47	1.22
Esophageal Epithelial Cells, donor2	11587-120G3	43.68	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	130.15	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	87.85	8.21	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	33.83	4.27	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	56.99	5.42	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	60.64	7.52	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	120.91	15.42	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	121.08	14.24	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	194.19	11.33	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	87.04	10.63	0.00
Fibroblast - Cardiac, donor1	11268-116G8	65.32	9.53	0.00
Fibroblast - Cardiac, donor2	11345-117G4	46.99	4.55	0.00
Fibroblast - Cardiac, donor3	11417-118F4	40.53	7.41	0.00
Fibroblast - Cardiac, donor4	11452-119A3	93.36	14.25	0.30
Fibroblast - Cardiac, donor5	11456-119A7	62.18	4.06	0.13
Fibroblast - Cardiac, donor6	11460-119B2	83.83	7.58	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	113.62	9.25	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	134.61	9.06	0.86
Fibroblast - Choroid Plexus, donor3	11653-122E6	45.41	7.32	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	54.66	8.99	1.15
Fibroblast - Conjunctival, donor3	11692-122I9	55.63	9.33	0.51
Fibroblast - Dermal, donor1	11269-116G9	57.76	5.17	0.00
Fibroblast - Dermal, donor2	11346-117G5	70.75	7.55	0.47
Fibroblast - Dermal, donor3	11418-118F5	50.41	6.77	0.60
Fibroblast - Dermal, donor4	11450-119A1	42.84	2.03	0.79
Fibroblast - Dermal, donor5	11454-119A5	50.07	1.92	0.17
Fibroblast - Dermal, donor6	11458-119A9	51.98	2.11	0.81
Fibroblast - Gingival, donor1	11237-116D4	67.67	8.75	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	89.08	7.86	0.79
Fibroblast - Gingival, donor2	11318-117D4	61.67	7.78	0.53
Fibroblast - Gingival, donor3	11394-118C8	85.18	9.77	0.77
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	108.04	38.44	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	81.05	18.50	0.18
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	113.49	14.81	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	103.72	10.55	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	274.89	21.88	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	110.85	10.53	0.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	110.99	10.91	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	82.27	9.21	0.55
Fibroblast - Gingival, donor9 (control)	11927-125I1	135.15	16.58	0.59
Fibroblast - Lung, donor1	11270-116H1	95.15	13.59	0.00
Fibroblast - Lung, donor2	11347-117G6	35.81	8.95	0.00
Fibroblast - Lung, donor3	11419-118F6	46.22	10.97	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	247.41	15.83	5.00
Fibroblast - Lymphatic, donor2	11586-120G2	151.05	11.19	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	132.38	14.83	0.56
Fibroblast - Mammary, donor1	11540-120B1	166.04	16.64	1.62
Fibroblast - Mammary, donor2	11620-122A9	143.79	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	273.99	29.78	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	44.42	4.27	0.78
Fibroblast - Periodontal Ligament, donor2	11319-117D5	71.14	6.98	0.46
Fibroblast - Periodontal Ligament, donor3	11395-118C9	63.95	7.65	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	98.84	10.69	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	60.21	7.83	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	81.53	18.32	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	46.64	5.31	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	86.76	17.27	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	97.56	9.35	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	57.33	10.67	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	127.60	6.75	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	52.22	4.97	0.53
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	52.23	7.88	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	124.25	6.92	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	76.43	5.61	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	127.80	9.36	0.51
Fibroblast - skin normal, donor1	11553-120C5	55.46	6.23	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	95.04	9.62	0.00
Fibroblast - skin normal, donor2	11561-120D4	57.56	3.72	0.70
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	154.75	7.86	0.91
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	70.34	7.12	0.50
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	57.10	5.98	1.03
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	107.07	8.21	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	49.53	2.45	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	47.74	6.58	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	41.09	4.08	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	87.15	11.33	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	104.71	9.01	1.21
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	112.68	15.61	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	131.33	12.01	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	38.28	1.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	39.56	1.28	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	49.35	5.13	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	61.77	4.69	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	46.35	2.74	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	55.28	4.36	0.99
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	57.89	4.76	1.32
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	43.05	2.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	58.37	4.86	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	39.43	3.53	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	49.63	4.06	0.37
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	44.86	4.57	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	50.80	7.68	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	55.09	6.51	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	42.69	6.10	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	47.92	4.56	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	53.19	4.73	0.75
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	64.92	5.90	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	50.53	6.21	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	46.42	3.81	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	54.07	6.48	0.89
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	49.40	4.44	0.60
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	40.21	4.58	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	48.24	6.47	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	66.80	5.10	2.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	69.68	4.44	2.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	42.05	3.65	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	39.52	4.24	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	37.77	3.47	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	42.91	3.09	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	54.30	4.27	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	36.86	4.34	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	49.60	3.75	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	53.26	4.06	1.11
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	41.50	2.27	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	66.39	3.53	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	41.98	3.13	0.57
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	40.65	3.01	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	50.48	4.87	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	39.93	4.08	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	40.62	3.07	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	44.05	5.33	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	39.26	5.18	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	34.23	5.35	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	49.42	7.50	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	29.66	4.27	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	48.79	3.52	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	49.59	4.79	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	45.18	4.82	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	75.37	4.96	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	53.95	6.99	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	53.67	4.44	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	81.84	6.86	1.02
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	46.18	4.18	1.19
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	48.69	4.01	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	56.87	6.34	0.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	23.78	1.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	18.65	2.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	25.83	3.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	37.12	4.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	29.40	3.87	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	24.07	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	33.04	5.22	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	30.92	3.91	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	38.30	3.71	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	26.66	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	24.89	3.64	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	29.42	1.96	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	39.43	2.52	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	36.58	5.09	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	31.93	2.04	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	27.15	6.26	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	42.95	1.72	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	31.37	2.66	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	30.49	8.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	29.41	4.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	32.22	3.45	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	19.22	1.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	28.69	1.96	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	30.10	2.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	37.37	2.31	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	28.07	2.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	49.70	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	35.86	1.42	1.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	31.38	3.02	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	44.25	7.63	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	39.49	1.60	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	36.51	2.47	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	24.79	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	33.26	2.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	47.84	3.51	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	19.50	2.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	16.12	2.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	18.92	1.46	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	260.22	49.08	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	203.75	37.01	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	184.41	34.86	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	170.32	19.66	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	82.30	7.10	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	22.28	2.67	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	22.45	4.05	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	16.38	4.10	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	21.32	3.50	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	25.36	5.80	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	20.02	2.37	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	22.42	3.61	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	21.10	4.46	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	13.46	2.24	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	159.49	10.07	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	123.35	15.58	1.30
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	71.38	5.29	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	79.36	10.58	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	122.05	11.62	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	54.03	7.87	0.17
Hepatocyte, donor1	11523-119I2	21.79	4.84	1.21
Hepatocyte, donor2	11603-120I1	64.64	22.62	0.00
Hepatocyte, donor3	11684-122I1	29.45	12.27	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	48.95	5.87	3.26
Intestinal epithelial cells (polarized), donor1	11246-116E4	22.72	4.89	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	34.58	7.41	1.23
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	140.09	25.47	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	73.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	162.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	78.91	9.69	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	85.09	5.01	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	106.81	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	102.52	7.69	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	82.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	155.94	6.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	88.37	10.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	54.46	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	124.41	7.94	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	64.30	9.98	4.43
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	104.77	10.48	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	82.51	7.56	2.52
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	75.78	6.19	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	93.68	11.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	115.91	12.88	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	71.69	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	100.23	9.78	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	83.12	5.88	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	93.23	10.45	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	62.78	6.46	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	64.67	7.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	52.60	12.70	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	77.48	8.61	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	83.85	7.62	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	98.20	5.74	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	92.96	14.58	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	15.80	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	76.40	11.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	106.19	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	20.85	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	60.81	5.86	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	105.36	10.54	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	138.30	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	113.35	8.34	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	108.44	11.07	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	142.65	16.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	119.45	7.85	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	96.74	9.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	108.02	17.42	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	89.61	10.67	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	108.06	9.70	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	151.03	17.10	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	96.64	8.28	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	84.71	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	117.96	12.42	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	84.59	10.57	1.06
Keratinocyte - epidermal, donor1	11272-116H3	104.28	5.79	0.82
Keratinocyte - epidermal, donor2	11349-117G8	54.46	4.10	0.59
Keratinocyte - epidermal, donor3	11421-118F8	63.70	8.24	0.38
Keratinocyte - oral, donor1	11251-116E9	91.04	7.95	0.79
Keratocytes, donor1	11527-119I6	60.17	22.01	0.34
Keratocytes, donor2	11607-120I5	75.00	4.69	0.00
Keratocytes, donor3	11688-122I5	61.45	17.78	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	65.94	6.59	0.00
Lens Epithelial Cells, donor1	11529-119I8	39.91	9.71	0.00
Lens Epithelial Cells, donor2	11609-120I7	46.59	8.53	1.27
Lens Epithelial Cells, donor3	11690-122I7	54.89	7.47	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	136.96	21.11	0.83
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	113.03	10.88	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	160.09	18.57	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	121.52	12.91	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	167.98	26.79	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	127.76	14.12	0.75
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	134.61	16.42	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	126.41	14.66	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	138.64	15.90	0.70
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	115.89	17.01	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	109.16	9.50	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	137.94	15.74	0.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	120.21	12.54	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	118.07	12.40	0.95
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	135.70	14.28	0.96
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	97.93	10.78	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	109.42	10.60	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	177.14	18.67	0.91
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	116.51	10.20	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	132.38	14.94	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	174.25	20.41	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	126.09	7.27	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	95.60	10.50	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	137.60	17.26	0.76
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	118.20	6.22	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	102.39	11.31	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	133.38	15.34	0.90
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	105.25	12.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	90.31	9.22	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	124.27	17.07	0.85
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	99.82	15.51	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	82.37	11.91	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	135.29	15.11	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	121.80	21.10	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	80.30	7.17	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	122.37	11.14	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	115.47	14.80	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	96.17	10.35	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	128.07	16.24	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	99.20	8.18	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	87.26	9.21	1.45
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	141.60	15.25	0.78
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	100.63	13.61	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	103.56	10.13	1.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	143.14	14.60	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	125.86	20.17	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	99.89	13.57	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	123.22	19.09	1.19
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	29.46	13.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	45.26	12.27	2.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	43.05	6.68	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	42.31	2.12	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	36.57	3.52	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	49.50	4.67	3.74
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	43.80	4.64	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	41.63	8.33	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	38.00	4.07	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	29.08	3.49	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	36.46	1.80	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	51.35	6.23	0.95
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	49.30	3.59	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	30.35	4.59	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	36.65	5.33	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	50.43	5.09	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	33.62	3.74	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	35.71	5.86	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	41.72	6.14	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	48.11	13.05	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	42.69	6.46	1.04
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	30.83	6.17	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	50.49	7.21	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	41.80	4.06	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	35.27	2.99	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	28.77	3.87	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	51.61	6.01	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	45.73	6.64	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	36.84	5.76	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	54.11	5.76	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	49.82	9.06	0.57
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	45.95	4.10	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	61.46	8.13	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	30.16	5.03	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	44.07	8.96	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	56.48	10.40	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	48.24	4.74	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	49.67	7.71	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	56.64	5.33	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	68.78	4.83	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	45.50	13.51	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	49.84	11.34	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	49.92	6.98	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	51.18	10.77	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	63.34	12.59	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	45.35	10.47	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	51.83	8.46	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	63.62	9.60	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	53.79	0.73	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	52.89	10.73	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	40.94	4.44	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	49.87	4.70	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	47.27	8.05	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	50.47	5.86	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	37.86	5.16	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	51.66	4.90	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	55.92	3.91	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	46.84	4.62	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	41.51	5.19	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	60.38	7.88	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	37.46	5.03	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	43.28	7.07	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	54.00	8.10	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	34.94	3.54	2.53
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	47.10	6.25	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	48.90	6.76	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	45.57	4.25	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	54.64	3.46	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	45.22	5.70	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	40.80	4.13	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	52.00	4.23	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	50.07	9.51	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	55.97	6.40	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	47.12	3.45	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	47.31	8.74	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	62.25	4.24	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	66.40	8.51	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	58.66	11.23	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	68.12	11.75	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	53.86	6.26	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	53.90	5.11	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	44.16	12.71	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	62.55	5.88	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	53.74	10.91	2.02
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	69.75	11.01	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	78.24	8.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	76.93	21.09	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	71.32	11.50	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	83.72	6.57	2.74
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	68.15	15.59	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	67.33	11.18	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	78.91	9.28	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	87.30	12.47	0.00
Macrophage - monocyte derived, donor1	11232-116C8	33.50	12.08	0.46
Macrophage - monocyte derived, donor2	11313-117C8	19.27	2.02	0.37
Macrophage - monocyte derived, donor3	11389-118C3	40.64	5.51	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	35.58	3.19	0.53
Mallassez-derived cells, donor2	11929-125I3	157.03	13.63	1.27
Mallassez-derived cells, donor3	11930-125I4	132.73	11.12	1.39
Mammary Epithelial Cell, donor1	11273-116H4	32.18	2.99	0.40
Mammary Epithelial Cell, donor2	11350-117G9	40.25	2.61	0.87
Mammary Epithelial Cell, donor3	11422-118F9	76.08	6.98	0.75
Mast cell - stimulated, donor1	11487-119E2	61.69	24.41	0.00
Mast cell, donor1	11563-120D6	58.07	22.60	0.11
Mast cell, donor2	11565-120D8	80.83	8.62	0.89
Mast cell, donor3	11566-120D9	192.03	24.54	1.58
Mast cell, donor4	11567-120E1	95.56	9.40	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	60.99	10.65	0.55
Mast cell, expanded and stimulated, donor8	11942-126A7	68.29	3.50	0.00
Mast cell, expanded, donor5	11939-126A4	51.40	15.49	0.11
Mast cell, expanded, donor8	11941-126A6	88.20	13.05	0.33
Melanocyte - dark, donor1	11502-119F8	117.11	6.27	0.30
Melanocyte - dark, donor2	11582-120F7	73.02	13.84	0.69
Melanocyte - dark, donor3	11663-122F7	42.52	5.00	0.22
Melanocyte - light, donor1	11274-116H5	62.06	9.64	0.00
Melanocyte - light, donor2	11351-117H1	62.10	8.87	0.00
Melanocyte - light, donor3	11423-118G1	50.30	6.94	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	36.03	1.67	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	43.30	5.92	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	78.48	18.48	0.00
Meningeal Cells, donor1	11493-119E8	103.96	7.44	0.74
Meningeal Cells, donor2	11573-120E7	73.50	7.92	1.76
Meningeal Cells, donor3	11654-122E7	55.34	8.39	0.41
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	48.48	4.28	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	37.64	3.42	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	310.14	27.60	3.94
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	107.27	2.62	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	60.28	4.31	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	43.20	9.11	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	55.29	9.55	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	74.50	6.59	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	91.32	6.58	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	90.03	5.73	0.61
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	77.43	4.02	0.83
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	79.55	11.52	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	47.50	7.63	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	86.35	5.34	1.19
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	65.40	9.34	4.67
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	100.54	3.84	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	46.08	3.54	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	31.90	6.88	1.25
Mesenchymal stem cells - umbilical, donor0	11214-116A8	52.98	5.81	0.00
Mesothelial Cells, donor1	11247-116E5	48.26	12.73	0.00
Mesothelial Cells, donor2	12156-128G5	52.55	9.01	0.00
Mesothelial Cells, donor3	11402-118D7	54.13	7.23	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	32.41	10.80	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	43.59	6.90	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	44.17	3.83	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	44.94	6.91	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	31.61	6.20	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	32.77	4.56	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	41.69	11.58	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	37.54	6.51	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	54.93	3.26	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	34.55	6.30	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	41.18	3.56	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	25.66	7.08	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	35.33	4.18	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	40.79	10.53	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	39.90	8.70	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	46.04	1.84	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	61.10	12.82	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	62.04	6.71	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	81.79	20.82	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	81.52	15.21	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	125.50	45.34	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	137.00	42.13	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	110.85	20.82	0.84
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	203.62	57.68	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	103.19	31.75	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	170.94	38.68	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	237.33	61.91	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	161.20	46.21	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	197.71	50.19	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	195.53	57.99	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	226.40	72.02	1.36
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	245.56	42.64	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	250.77	59.97	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	172.52	56.71	1.44
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	236.54	49.63	2.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	329.09	68.56	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	229.26	88.60	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	242.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	275.20	83.58	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	221.59	55.62	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	281.43	50.77	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	340.05	108.87	1.28
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	225.36	79.33	0.99
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	249.13	45.23	2.09
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	329.27	97.23	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	186.32	82.73	1.03
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	349.65	68.71	3.94
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	306.80	62.50	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	209.85	65.93	1.40
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	248.55	53.62	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	374.71	97.90	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	244.35	69.99	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	234.99	37.57	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	433.13	36.09	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	260.44	57.26	2.77
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	387.00	52.93	2.28
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	263.51	72.68	0.97
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	235.31	67.64	1.30
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	343.18	58.34	1.29
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	329.03	87.02	1.27
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	277.30	76.60	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	162.84	29.63	1.50
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	148.03	45.77	0.99
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	196.52	54.47	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	334.57	57.49	0.88
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	257.86	80.77	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	217.34	56.82	1.42
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	278.74	50.64	1.47
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	160.31	54.09	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	161.72	52.63	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	123.12	31.72	0.58
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	70.48	24.73	1.65
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	142.64	43.18	1.19
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	12.48	3.56	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	33.51	12.81	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	15.78	3.16	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	16.21	1.98	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	23.28	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	25.54	3.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	19.98	1.60	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	19.11	3.62	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	24.31	4.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	32.61	7.33	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	28.00	4.67	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	18.17	6.41	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	57.96	11.59	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	44.44	11.11	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	23.19	5.90	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	87.16	80.35	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	48.96	34.97	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	42.92	34.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	39.27	37.76	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	468.23	354.03	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	287.10	97.87	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	185.35	99.80	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	200.78	112.94	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	31.24	2.80	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	45.99	3.66	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	52.73	4.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	35.06	4.17	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	173.03	11.60	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	75.01	6.38	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	42.16	1.36	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	180.09	25.73	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	32.65	3.35	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	44.40	9.30	0.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	76.47	7.57	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	84.94	8.83	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	167.02	66.81	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	69.49	4.47	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	77.68	7.85	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	43.07	4.08	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	91.78	11.43	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	69.07	9.48	0.91
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	49.33	4.77	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	49.23	1.80	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	291.42	22.97	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	42.44	4.72	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	72.32	8.64	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	40.08	2.81	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	60.22	4.14	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	46.27	5.78	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	165.55	14.83	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	596.71	103.67	7.59
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	70.18	7.57	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	35.14	5.50	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	100.16	8.31	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	51.08	4.29	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	108.33	18.06	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	75.31	8.66	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	68.08	7.66	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	28.17	1.98	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	67.79	4.64	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	43.89	6.05	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	47.58	4.89	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	84.11	5.67	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	86.84	5.88	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	33.51	3.53	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	59.84	5.32	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	67.46	2.48	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	52.83	4.21	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	81.96	15.12	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	85.76	6.41	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	34.56	3.39	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	403.65	71.53	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	60.97	5.49	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	53.19	8.18	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	92.61	8.17	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	35.60	2.37	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	321.95	26.07	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	232.66	40.46	0.00
Myoblast, donor1	11241-116D8	49.44	7.21	0.25
Myoblast, donor2	11322-117D8	42.39	4.79	0.77
Myoblast, donor3	11398-118D3	37.16	3.87	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	48.16	13.57	0.44
Natural Killer Cells, donor1	11230-116C6	63.04	24.29	0.00
Natural Killer Cells, donor2	11311-117C6	54.28	27.44	0.90
Natural Killer Cells, donor3	11387-118C1	57.61	22.64	0.18
Neural stem cells, donor1	11275-116H6	52.99	4.36	0.73
Neural stem cells, donor2	11352-117H2	38.51	9.63	5.78
Neurons, donor1	11494-119E9	19.34	3.41	1.14
Neurons, donor2	11574-120E8	39.63	2.42	1.98
Neurons, donor3	11655-122E8	18.09	3.29	0.82
Neutrophils, donor1	11233-116C9	62.18	42.69	0.00
Neutrophils, donor2	11314-117C9	31.89	34.79	0.00
Neutrophils, donor3	11390-118C4	106.29	59.86	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	68.15	5.82	1.19
Nucleus Pulposus Cell, donor2	11409-118E5	69.03	6.84	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	57.56	2.01	0.60
Olfactory epithelial cells, donor1	11933-125I7	57.13	12.80	0.96
Olfactory epithelial cells, donor2	11934-125I8	61.08	11.29	0.14
Olfactory epithelial cells, donor3	11935-125I9	72.53	8.29	0.23
Olfactory epithelial cells, donor4	11936-126A1	128.47	14.51	0.78
Oligodendrocyte - precursors, donor1	11496-119F2	45.74	7.22	0.60
Osteoblast - differentiated, donor1	11276-116H7	95.71	9.36	0.21
Osteoblast - differentiated, donor2	11353-117H3	65.16	11.43	0.00
Osteoblast - differentiated, donor3	11425-118G3	31.66	3.72	0.00
Osteoblast, donor1	11277-116H8	71.14	7.82	0.59
Osteoblast, donor2	11354-117H4	43.54	4.92	1.40
Osteoblast, donor3	11426-118G4	49.05	6.40	0.53
Pancreatic stromal cells, donor1	11249-116E7	54.58	8.59	0.51
Pericytes, donor1	11491-119E6	97.25	7.23	1.11
Pericytes, donor2	11571-120E5	89.64	5.21	0.45
Pericytes, donor3	11652-122E5	107.83	15.46	0.41
Perineurial Cells, donor1	11499-119F5	65.67	8.48	0.68
Perineurial Cells, donor2	11579-120F4	77.47	12.51	0.55
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	59.29	19.76	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	39.67	16.90	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	52.93	19.15	0.52
Placental Epithelial Cells, donor1	11278-116H9	28.46	1.20	0.24
Placental Epithelial Cells, donor2	11355-117H5	36.59	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	37.11	1.37	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	34.49	2.85	0.00
Preadipocyte - breast, donor1	11467-119B9	53.09	3.00	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	76.49	6.40	0.65
Preadipocyte - breast, donor2	11328-117E5	64.84	4.95	0.68
Preadipocyte - omental, donor1	11468-119C1	59.35	6.07	0.32
Preadipocyte - omental, donor2	11329-117E6	61.54	6.98	0.44
Preadipocyte - omental, donor3	11403-118D8	61.88	8.31	0.43
Preadipocyte - perirenal, donor1	11469-119C2	33.47	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	103.50	21.50	1.23
Preadipocyte - subcutaneous, donor2	11356-117H6	108.73	18.24	1.24
Preadipocyte - subcutaneous, donor3	11428-118G6	60.79	12.26	0.51
Preadipocyte - visceral, donor1	11280-116I2	80.85	10.90	1.02
Preadipocyte - visceral, donor2	11357-117H7	87.43	14.27	0.92
Preadipocyte - visceral, donor3	11429-118G7	71.26	9.93	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	13.73	2.56	0.15
Prostate Epithelial Cells, donor2	11331-117E8	79.62	7.18	0.41
Prostate Epithelial Cells, donor3	11404-118D9	17.39	0.18	0.31
Prostate Stromal Cells, donor1	11254-116F3	34.17	8.43	0.11
Prostate Stromal Cells, donor2	11332-117E9	48.05	11.65	0.72
Prostate Stromal Cells, donor3	11405-118E1	38.06	13.14	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	81.03	9.85	1.82
Renal Cortical Epithelial Cells, donor2	11596-120H3	42.21	2.56	0.97
Renal Epithelial Cells, donor1	11517-119H5	131.88	10.14	2.03
Renal Epithelial Cells, donor2	11597-120H4	118.79	11.38	1.42
Renal Epithelial Cells, donor3	11678-122H4	78.55	8.05	0.74
Renal Glomerular Endothelial Cells, donor1	11514-119H2	132.09	11.57	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	109.56	7.68	1.08
Renal Glomerular Endothelial Cells, donor3	11675-122H1	107.23	13.54	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	130.43	20.63	0.00
Renal Mesangial Cells, donor1	11518-119H6	72.19	10.56	1.98
Renal Mesangial Cells, donor2	11598-120H5	97.81	5.02	3.13
Renal Mesangial Cells, donor3	11679-122H5	118.18	11.37	1.66
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	77.84	9.66	1.61
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	62.83	5.06	2.11
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	103.94	15.81	1.16
Retinal Pigment Epithelial Cells, donor0	11215-116A9	25.41	1.56	1.04
Retinal Pigment Epithelial Cells, donor1	11528-119I7	55.71	6.54	1.42
Retinal Pigment Epithelial Cells, donor2	11608-120I6	51.46	11.32	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	29.86	3.01	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	55.46	9.62	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	28.59	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	33.57	6.60	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	29.58	6.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	22.23	1.17	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	21.75	3.28	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	17.18	3.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	22.45	2.23	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	16.90	3.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	24.27	6.01	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	30.94	3.15	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	20.12	2.12	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	15.41	2.87	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	28.69	2.15	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	18.03	2.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	19.25	3.98	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	31.74	2.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	23.20	4.19	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	19.92	2.44	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	31.19	2.65	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	18.79	2.82	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	21.39	3.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	22.96	2.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	19.62	1.68	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	18.63	3.93	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	24.80	2.73	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	15.57	3.92	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	17.46	1.75	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	32.79	2.59	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	16.27	2.98	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	19.88	2.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	24.26	1.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	14.16	2.21	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	19.22	2.92	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	27.46	2.56	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	18.39	4.09	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	22.17	1.54	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	30.60	1.72	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	23.87	4.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	22.82	1.64	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	32.04	2.56	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	18.05	4.44	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	31.19	3.73	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	29.87	2.90	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	16.19	3.10	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	34.67	4.43	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	23.07	1.22	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	23.41	3.49	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	23.87	4.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	23.13	3.55	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	26.49	7.57	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	19.47	3.04	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	25.92	1.51	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	27.82	2.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	32.35	6.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	18.42	2.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	22.41	6.62	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	17.43	5.41	0.00
Schwann Cells, donor1	11498-119F4	103.44	7.52	0.56
Schwann Cells, donor2	11578-120F3	68.05	0.00	0.00
Schwann Cells, donor3	11659-122F3	55.87	7.45	0.22
Sebocyte, donor1	11220-116B5	194.46	29.03	1.64
Sebocyte, donor2	11301-117B5	156.25	9.65	0.46
Sebocyte, donor3	11378-118B1	157.88	9.89	0.82
Sertoli Cells, donor1	11255-116F4	99.40	19.88	0.00
Sertoli Cells, donor2	11333-117F1	93.20	14.12	0.00
Skeletal Muscle Cells, donor1	11281-116I3	44.34	8.36	0.35
Skeletal Muscle Cells, donor2	11358-117H8	36.14	5.06	0.72
Skeletal Muscle Cells, donor3	11430-118G8	131.26	6.69	2.51
Skeletal Muscle Cells, donor4	11451-119A2	66.92	4.87	0.79
Skeletal Muscle Cells, donor5	11455-119A6	75.21	6.69	0.59
Skeletal Muscle Cells, donor6	11459-119B1	62.18	4.77	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	105.59	11.72	1.01
Skeletal Muscle Satellite Cells, donor2	11321-117D7	93.60	11.13	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	72.22	10.12	0.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	66.31	11.46	0.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	56.45	8.69	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	44.44	3.58	0.41
Skin - palm, donor1	10286-104F7	131.62	32.23	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	58.38	1.01	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	189.75	1.64	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	68.55	3.38	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	34.47	2.22	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	50.07	3.09	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	152.88	8.03	1.90
Small Airway Epithelial Cells, donor3	11406-118E2	45.87	2.70	0.45
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	78.69	3.39	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	130.06	5.11	1.33
Smooth Muscle Cells - Aortic, donor0	11210-116A4	59.96	11.76	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	142.10	63.42	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	72.06	8.27	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	71.08	8.50	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	52.04	8.01	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	50.04	4.66	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	39.68	6.65	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	11.27	0.77	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	64.79	8.47	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	57.88	7.09	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	94.53	14.09	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	59.70	7.32	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	87.07	8.83	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	101.53	19.70	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	116.29	36.72	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	68.19	8.11	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	42.62	4.28	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	52.09	7.75	1.29
Smooth Muscle Cells - Colonic, donor3	11396-118D1	51.32	6.61	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	79.97	10.67	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	102.40	10.78	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	62.46	5.38	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	66.91	9.22	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	33.22	3.30	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	81.32	7.35	0.40
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	240.52	88.75	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	64.00	1.81	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	45.04	5.03	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	53.26	7.46	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	53.34	10.77	1.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	41.09	10.65	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	92.27	13.42	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	96.77	16.50	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	103.38	3.88	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	51.62	6.51	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	95.42	19.69	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	135.39	19.12	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	62.54	9.14	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	43.99	6.83	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	60.73	11.21	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	34.54	4.89	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	56.09	6.12	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	47.20	5.64	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	61.49	4.05	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	46.33	4.78	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	88.57	11.90	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	37.68	3.91	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	45.29	3.31	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	36.86	4.10	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	68.03	4.66	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	68.49	4.76	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	66.58	5.58	1.49
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	76.90	7.91	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	35.49	2.56	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	50.02	2.36	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	45.46	6.09	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	65.89	10.78	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	45.56	4.60	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	41.25	4.58	0.00
Synoviocyte, donor1	11291-117A4	44.27	6.90	0.17
Synoviocyte, donor2	11368-117I9	33.36	8.72	0.34
Synoviocyte, donor3	11440-118H9	42.45	6.26	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	65.03	5.72	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	87.21	15.86	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	51.17	4.40	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	51.25	3.01	1.22
Tracheal Epithelial Cells, donor2	11369-118A1	79.63	6.96	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	76.16	6.87	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	59.79	9.10	0.37
Urethra, donor2	10319-105A4	161.86	21.58	0.00
Urothelial Cells, donor1	11520-119H8	128.05	13.28	1.06
Urothelial Cells, donor2	11600-120H7	112.16	12.02	0.80
Urothelial Cells, donor3	11681-122H7	115.98	11.00	0.92
Urothelial cells, donor0	11216-116B1	84.48	14.27	1.78
Whole blood (ribopure), donor090309, donation1	12179-129A1	70.29	14.24	2.67
Whole blood (ribopure), donor090309, donation2	12180-129A2	68.62	7.15	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	49.29	22.59	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	47.86	13.43	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	44.16	7.55	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	60.39	8.33	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	59.66	6.42	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	52.95	16.43	0.00
Wilms' tumor cell line:G-401	10809-111A8	34.42	5.06	0.86
Wilms' tumor cell line:HFWT	10597-108E3	22.00	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	24.58	2.79	0.00
achilles tendon, donor2	10292-104G4	111.59	43.40	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	38.50	6.37	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	50.85	4.88	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	48.79	11.87	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	91.97	7.35	4.08
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	105.97	16.30	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	86.07	15.44	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	145.36	17.15	1.91
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	61.69	3.97	2.20
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	99.64	16.74	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	46.21	22.52	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	88.50	5.89	2.02
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	167.72	7.80	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	138.73	13.48	2.79
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	48.41	8.54	1.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	61.66	16.66	1.17
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	75.76	12.08	1.86
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	79.37	8.23	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	50.03	8.29	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	40.11	14.51	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	38.21	15.77	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	43.81	14.44	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	49.45	5.79	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	67.38	5.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	59.46	13.01	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	44.07	3.01	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	199.31	13.08	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	101.22	18.74	0.00
adenocarcinoma cell line:IM95m	10796-110I4	35.09	6.36	0.47
adipose tissue, adult, pool1	10010-101C1	154.50	24.04	1.09
adipose, donor1	10184-103D4	56.30	4.69	0.59
adipose, donor2	10185-103D5	36.90	1.22	1.22
adipose, donor3	10186-103D6	37.30	3.54	0.00
adipose, donor4	10187-103D7	51.14	3.47	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	36.14	1.10	3.63
adrenal gland, adult, pool1	10081-102A9	54.57	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	70.97	5.47	0.80
alveolar cell carcinoma cell line:SW 1573	10708-109H6	40.02	6.43	0.36
amniotic membrane cells, donor1	12235-129G3	19.24	1.39	0.00
amniotic membrane cells, donor2	12236-129G4	18.26	1.35	0.34
amniotic membrane cells, donor3	12237-129G5	29.46	0.59	0.88
amygdala - adult, donor10196	10167-103B5	59.29	7.11	1.19
amygdala, adult, donor10252	10151-102I7	68.74	8.52	1.01
amygdala, newborn, donor10223	10360-105E9	44.86	3.87	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	157.51	31.20	2.16
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	47.43	12.35	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	48.44	9.69	0.00
aorta, adult, pool1	10052-101G7	81.59	13.14	0.98
appendix, adult	10189-103D9	143.22	21.73	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	28.89	2.06	0.34
artery, adult	10190-103E1	51.63	9.51	0.00
astrocytoma cell line:TM-31	10425-106D2	44.18	8.69	0.29
b cell line:RPMI1788	10427-106D4	101.86	16.36	1.78
basal cell carcinoma cell line:TE 354.T	10702-109G9	37.18	5.55	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	56.26	9.92	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	43.69	7.53	1.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	31.32	7.27	0.00
bladder, adult, pool1	10011-101C2	69.53	6.84	0.54
blood, adult, pool1	10053-101G8	39.86	31.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	59.94	13.70	0.00
bone marrow, adult	10192-103E3	133.62	24.29	0.00
brain, adult, donor1	10084-102B3	49.20	3.08	0.00
brain, adult, pool1	10012-101C3	37.64	4.45	0.67
brain, fetal, pool1	10085-102B4	40.07	5.34	5.34
breast carcinoma cell line:MCF7	10482-107A5	16.52	0.99	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	11.98	0.50	0.12
breast, adult, donor1	10080-102A8	150.26	8.84	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	51.07	5.21	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	59.68	9.90	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	62.85	3.91	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	48.18	3.63	0.48
carcinoid cell line:NCI-H1770	10703-109H1	28.21	1.41	1.41
carcinoid cell line:NCI-H727	10735-110B6	33.36	1.97	0.88
carcinoid cell line:SK-PN-DW	10719-109I8	23.77	0.00	1.27
carcinosarcoma cell line:JHUCS-1	10642-109A3	43.65	4.79	1.33
caudate nucleus - adult, donor10196	10177-103C6	57.57	2.30	2.30
caudate nucleus, adult, donor10252	10164-103B2	57.56	5.52	1.84
caudate nucleus, adult, donor10258	10379-105H1	29.80	3.06	3.06
caudate nucleus, newborn, donor10223	10354-105E3	47.98	4.39	0.73
cerebellum - adult, donor10196	10173-103C2	78.66	0.00	5.83
cerebellum, adult, donor10252	10166-103B4	83.06	4.27	2.56
cerebellum, adult, pool1	10083-102B2	22.42	1.72	0.00
cerebellum, newborn, donor10223	10357-105E6	91.33	1.66	3.32
cerebral meninges, adult	10188-103D8	36.06	3.78	0.25
cerebrospinal fluid, donor2	10294-104G6	19.00	2.92	0.00
cervical cancer cell line:D98-AH2	10552-107I3	29.19	2.59	1.15
cervical cancer cell line:ME-180	10553-107I4	25.35	3.15	0.33
cervix, adult, pool1	10013-101C4	111.50	17.95	0.42
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	36.37	7.80	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	32.66	6.53	0.00
choriocarcinoma cell line:BeWo	10423-106C9	47.47	5.22	0.25
choriocarcinoma cell line:SCH	10785-110H2	16.39	2.46	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	64.51	1.90	2.37
chorionic membrane cells, donor1	12238-129G6	21.37	3.99	0.00
chorionic membrane cells, donor2	12239-129G7	62.24	10.34	0.30
chorionic membrane cells, donor3	12240-129G8	48.90	2.75	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	46.45	8.08	3.03
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	58.21	12.29	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	77.08	13.30	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	82.95	4.88	1.28
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	77.64	8.47	0.97
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	79.20	6.72	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	26.80	2.94	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	140.74	17.72	1.04
clear cell carcinoma cell line:JHOC-5	10638-108I8	64.69	6.86	0.46
clear cell carcinoma cell line:TEN	10636-108I6	37.48	6.25	0.17
colon carcinoma cell line:CACO-2	10513-107D9	19.59	2.75	0.37
colon carcinoma cell line:COLO-320	10420-106C6	39.15	1.52	1.14
colon, adult, donor1	10082-102B1	66.64	8.33	2.38
colon, adult, pool1	10014-101C5	74.61	14.45	0.24
colon, fetal, donor1	10070-101I7	68.60	12.36	0.62
common myeloid progenitor CMP, donor1	12130-128D6	220.01	50.42	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	32.72	8.07	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	33.96	8.30	0.75
cord blood derived cell line:COBL-a untreated	10449-106F8	37.51	11.84	0.28
corpus callosum, adult, pool1	10042-101F6	45.11	6.97	0.77
cruciate ligament, donor2	10295-104G7	127.24	21.07	0.00
diaphragm, fetal, donor1	10069-101I6	60.19	6.42	0.00
diencephalon, adult	10193-103E4	29.52	1.92	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	28.93	4.59	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	13.85	1.54	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	31.29	4.09	0.72
ductus deferens, adult	10196-103E7	93.69	7.97	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	53.29	11.52	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	101.52	20.60	0.00
dura mater, adult, donor1	10041-101F5	91.84	41.29	0.74
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	75.73	22.21	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	34.39	1.72	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	51.80	11.72	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	57.82	8.17	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	57.43	9.88	0.00
embryonic pancreas cell line:2C6	10603-108E9	70.93	18.39	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	9.05	5.03	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	60.53	6.16	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	17.85	1.45	0.16
epidermoid carcinoma cell line:A431	10426-106D3	87.15	15.34	1.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	51.36	6.27	0.44
epididymis, adult	10197-103E8	82.68	17.79	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	28.39	5.50	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	29.89	12.58	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	40.76	4.59	0.66
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	36.91	6.00	0.69
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	41.23	5.83	0.34
esophagus, adult, pool1	10015-101C6	57.34	6.69	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	46.09	4.13	0.75
eye - muscle inferior rectus, donor1	10272-104E2	212.48	21.73	2.41
eye - muscle lateral, donor2	10298-104H1	101.00	16.83	0.00
eye - muscle medial, donor2	10299-104H2	69.95	17.86	1.49
eye - muscle superior, donor2	10297-104G9	74.52	19.49	0.00
eye - vitreous humor, donor1	10268-104D7	36.43	2.91	0.00
eye, fetal, donor1	10054-101G9	51.61	5.59	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	38.72	7.57	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	94.26	7.36	1.90
frontal lobe, adult, pool1	10040-101F4	34.06	4.79	0.84
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	68.46	26.12	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	30.54	2.93	0.37
gall bladder, adult	10198-103E9	95.85	13.52	0.24
gamma delta positive T cells, donor1	11937-126A2	66.57	19.86	0.00
gamma delta positive T cells, donor2	11938-126A3	48.93	17.93	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	34.22	13.10	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	42.94	4.06	0.00
gastric cancer cell line:AZ521	10549-107H9	31.97	2.30	0.49
gastric cancer cell line:GSS	10560-108A2	37.52	0.00	5.49
gastrointestinal carcinoma cell line:ECC12	10615-108G3	27.19	1.14	0.23
giant cell carcinoma cell line:LU65	10487-107B1	32.93	3.90	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	103.43	8.96	1.12
glassy cell carcinoma cell line:HOKUG	10688-109F4	52.88	4.24	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	90.99	15.52	0.63
glioblastoma cell line:A172, tech_rep2	10444-106F3	86.23	16.15	0.70
glioblastoma cell line:T98G	10485-107A8	48.45	13.24	0.44
glioma cell line:GI-1	10413-106B8	49.50	9.96	1.17
globus pallidus - adult, donor10196	10175-103C4	70.70	11.66	0.00
globus pallidus, adult, donor10252	10161-103A8	74.94	11.96	1.95
globus pallidus, adult, donor10258	10367-105F7	46.55	6.85	2.74
globus pallidus, newborn, donor10223	10364-105F4	68.75	3.73	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	70.97	46.50	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	26.13	10.45	0.00
granulosa cell tumor cell line:KGN	10624-108H3	55.04	10.88	0.00
hIPS +CCl2, biol_rep1	14383-156B9	46.37	5.05	0.00
hIPS +CCl2, biol_rep2	14384-156C1	40.70	2.74	0.91
hIPS +CCl2, biol_rep3	14385-156C2	54.10	2.58	1.93
hIPS, biol_rep1	14380-156B6	51.74	1.44	1.44
hIPS, biol_rep2	14381-156B7	42.52	1.37	0.69
hIPS, biol_rep3	14382-156B8	30.90	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	62.07	7.47	1.72
heart - mitral valve, adult	10205-103F7	87.60	15.55	0.90
heart - pulmonic valve, adult	10206-103F8	75.57	11.77	0.26
heart - tricuspid valve, adult	10207-103F9	135.72	22.48	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	39.59	3.26	0.61
heart, adult, diseased, donor1	10051-101G6	64.30	13.20	0.00
heart, adult, pool1	10016-101C7	40.94	6.67	0.46
heart, fetal, pool1	10046-101G1	72.80	9.65	0.62
hepatic mesenchymal tumor cell line:LI90	10778-110G4	51.21	3.70	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	28.54	2.38	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	29.83	6.41	0.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	32.04	7.16	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	32.54	6.67	0.40
hepatoma cell line:Li-7	10484-107A7	16.79	6.67	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	49.65	13.07	1.01
hippocampus - adult, donor10196	10169-103B7	65.30	5.68	0.00
hippocampus, adult, donor10252	10153-102I9	62.45	5.92	1.63
hippocampus, adult, donor10258	10374-105G5	39.84	2.49	0.50
hippocampus, newborn, donor10223	10363-105F3	42.65	4.93	1.76
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	47.00	5.49	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	37.70	3.73	1.37
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	40.62	4.32	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	40.03	4.51	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	46.22	2.32	0.52
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	42.90	1.52	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	39.71	2.34	1.75
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	43.30	1.94	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	41.29	3.34	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	24.86	1.66	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	38.41	2.25	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	24.91	1.35	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	35.52	4.07	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	36.36	5.90	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	49.75	1.75	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	51.74	3.05	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	50.15	2.18	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	64.97	3.50	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	38.62	1.51	2.07
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	34.10	1.82	1.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	44.79	1.25	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	30.86	2.94	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	31.64	1.74	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	39.16	3.29	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	43.05	5.91	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	40.51	3.14	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	52.26	6.12	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	47.53	3.87	1.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	43.71	3.80	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	45.09	1.21	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	36.72	2.07	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	38.52	2.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	34.63	4.10	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	25.82	2.56	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	43.16	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	39.65	2.69	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	40.09	4.35	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	57.94	4.01	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	48.78	5.85	0.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	46.15	3.67	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	71.57	0.00	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	65.20	2.65	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	45.43	3.28	3.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	47.77	2.90	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	42.70	0.71	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	41.77	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	48.21	1.90	0.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	34.75	2.69	0.54
immature langerhans cells, donor1	11904-125F5	24.21	5.33	0.24
immature langerhans cells, donor2	11905-125F6	32.48	6.34	0.00
insula, adult, pool1	10039-101F3	42.96	4.54	1.04
keratoacanthoma cell line:HKA-1	10791-110H8	23.41	2.60	0.00
kidney, adult, pool1	10017-101C8	41.15	7.11	0.30
kidney, fetal, pool1	10045-101F9	84.60	10.40	0.71
large cell lung carcinoma cell line:IA-LM	10509-107D5	68.74	21.45	0.71
large cell lung carcinoma cell line:NCI-H460	10839-111E2	23.36	1.80	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	50.83	6.42	0.55
left atrium, adult, donor1	10079-102A7	59.93	5.45	0.00
left ventricle, adult, donor1	10078-102A6	57.14	4.05	0.00
leiomyoblastoma cell line:G-402	10721-110A1	22.71	2.19	0.55
leiomyoma cell line:10964C	10569-108B2	57.84	11.50	0.00
leiomyoma cell line:15242A	10570-108B3	39.13	10.87	0.00
leiomyoma cell line:15425	10571-108B4	64.59	8.50	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	44.45	12.70	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	37.64	13.59	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	113.22	37.42	0.83
liposarcoma cell line:KMLS-1	10782-110G8	79.98	7.03	0.78
liposarcoma cell line:SW 872	10726-110A6	69.81	33.51	0.61
liver, adult, pool1	10018-101C9	23.34	5.51	0.00
liver, fetal, pool1	10086-102B5	22.58	1.88	0.94
locus coeruleus - adult, donor10196	10182-103D2	75.68	13.56	1.60
locus coeruleus, adult, donor10252	10165-103B3	57.40	10.89	0.37
locus coeruleus, adult, donor10258	10375-105G6	24.26	3.39	0.85
locus coeruleus, newborn, donor10223	10362-105F2	86.23	2.94	0.00
lung adenocarcinoma cell line:A549	10499-107C4	11.90	0.42	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	43.43	3.45	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	44.29	6.20	0.40
lung, adult, pool1	10019-101D1	92.73	19.61	0.00
lung, fetal, donor1	10068-101I5	280.27	17.41	2.00
lung, right lower lobe, adult, donor1	10075-102A3	146.17	43.99	0.92
lymph node, adult, donor1	10077-102A5	79.05	11.83	0.47
lymphangiectasia cell line:DS-1	10727-110A7	25.21	2.63	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	71.54	10.11	0.91
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	248.05	44.17	0.00
mature adipocyte, donor1	12231-129F8	43.07	9.77	0.00
mature adipocyte, donor2	12232-129F9	73.46	13.70	0.83
mature adipocyte, donor3	12233-129G1	59.27	10.43	0.24
mature adipocyte, donor4	12234-129G2	44.22	3.42	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	22.16	0.71	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	56.40	5.64	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	89.56	9.56	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	37.17	1.59	1.59
medial frontal gyrus, newborn, donor10223	10352-105E1	49.90	8.10	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	52.14	6.41	1.35
medial temporal gyrus, adult, donor10252	10156-103A3	82.56	8.70	1.70
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	21.19	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	28.71	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	70.71	5.38	1.08
medulla oblongata - adult, donor10196	10174-103C3	66.84	2.60	1.95
medulla oblongata, adult, donor10252	10155-103A2	62.70	6.04	1.24
medulla oblongata, adult, pool1	10038-101F2	50.20	9.88	0.82
medulla oblongata, newborn, donor10223	10361-105F1	61.10	7.29	1.04
medulloblastoma cell line:D283 Med	10838-111E1	50.48	3.10	0.44
medulloblastoma cell line:ONS-76	10759-110E3	26.29	2.93	0.61
melanoma cell line:COLO 679	10514-107E1	24.29	0.29	0.00
melanoma cell line:G-361	10465-106H6	55.65	0.81	0.00
meningioma cell line:HKBMM	10691-109F7	97.15	34.19	1.27
merkel cell carcinoma cell line:MKL-1	10843-111E6	40.53	3.52	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	42.51	2.59	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	67.66	6.60	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	54.17	7.82	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	88.62	6.21	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	67.01	6.32	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	62.39	11.75	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	119.38	15.27	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	40.68	7.38	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	78.90	12.08	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	54.12	5.04	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	55.23	4.86	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	85.93	6.69	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	57.97	12.19	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	83.16	10.24	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	92.51	13.61	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	58.80	3.88	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	85.19	11.86	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	52.55	4.97	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	76.15	7.98	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	109.92	7.13	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	59.03	6.87	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	75.36	8.84	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	61.85	7.73	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	105.59	11.73	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	58.10	8.00	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	49.78	4.57	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	46.55	5.63	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	52.87	6.28	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	68.70	9.86	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	58.60	5.18	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	60.58	8.12	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	67.59	7.07	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	61.17	5.56	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	73.83	7.79	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	68.71	8.03	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	73.79	7.21	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	71.87	4.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	58.40	8.73	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	69.18	8.60	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	75.60	6.87	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	68.36	8.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	36.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	56.19	3.90	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	42.19	2.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	47.98	3.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	47.43	2.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	47.04	5.05	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	41.97	6.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	43.71	3.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	47.67	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	52.18	5.93	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	62.14	3.66	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	40.54	8.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	30.01	2.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	21.49	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	35.93	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	26.08	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	22.24	2.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	28.30	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	28.05	1.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	26.73	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	36.66	8.28	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	35.95	10.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	34.42	6.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	26.22	2.47	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	32.52	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	26.08	3.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	23.37	2.82	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	30.53	6.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	21.54	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	41.88	3.03	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	31.63	9.04	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	35.42	4.12	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	23.61	1.39	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	27.91	5.19	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	39.73	8.15	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	43.33	11.61	2.32
mesothelioma cell line:ACC-MESO-1	10493-107B7	62.13	13.94	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	83.40	18.30	0.93
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	55.56	21.37	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	81.89	20.24	0.72
mesothelioma cell line:Mero-25	10850-111F4	50.16	15.66	0.23
mesothelioma cell line:Mero-41	10851-111F5	95.35	15.40	0.73
mesothelioma cell line:Mero-48a	10852-111F6	79.72	8.64	0.44
mesothelioma cell line:Mero-82	10853-111F7	162.41	65.18	0.53
mesothelioma cell line:Mero-83	10854-111F8	28.77	3.40	0.17
mesothelioma cell line:Mero-84	10855-111F9	39.69	1.77	0.25
mesothelioma cell line:Mero-95	10856-111G1	154.04	18.01	1.66
mesothelioma cell line:NCI-H2052	10847-111F1	67.58	7.62	0.17
mesothelioma cell line:NCI-H226	10846-111E9	72.58	9.23	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	134.61	38.09	0.85
mesothelioma cell line:NCI-H28	10845-111E8	104.59	11.20	1.78
mesothelioma cell line:No36	10857-111G2	12.72	2.28	0.00
mesothelioma cell line:ONE58	10858-111G3	77.22	23.57	0.54
migratory langerhans cells, donor1	11901-125F2	71.20	5.95	1.73
migratory langerhans cells, donor2	11902-125F3	65.09	6.59	0.85
migratory langerhans cells, donor3	11903-125F4	63.72	7.72	1.26
mixed mullerian tumor cell line:HTMMT	10689-109F5	59.42	14.69	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	35.39	8.05	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	21.88	1.38	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	42.24	15.79	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	41.21	10.16	0.55
myeloma cell line:PCM6	10474-106I6	46.25	9.09	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	118.20	12.68	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	66.10	9.02	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	17.94	0.11	0.22
nasal epithelial cells, donor1, tech_rep2	12226-129F3	18.68	0.44	0.29
nasal epithelial cells, donor2	12227-129F4	14.90	2.21	0.55
neuroblastoma cell line:CHP-134	10508-107D4	38.65	0.46	1.84
neuroblastoma cell line:NB-1	10539-107G8	43.97	2.99	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	15.39	1.05	0.00
neuroblastoma cell line:NH-12	10555-107I6	56.09	2.24	2.61
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	46.50	0.95	2.85
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	42.29	1.58	1.58
neuroectodermal tumor cell line:TASK1	10774-110F9	19.72	1.01	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	23.52	0.00	1.27
neurofibroma cell line:Hs 53.T	10729-110A9	57.76	9.05	0.27
neutrophil PMN, donor1	12133-128D9	29.75	29.75	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	55.98	11.16	0.68
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	16.81	1.60	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	28.85	4.17	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	58.60	26.54	0.53
nucleus accumbens, adult, pool1	10037-101F1	36.56	5.44	0.94
occipital cortex - adult, donor10196	10172-103C1	49.45	2.06	4.12
occipital cortex, adult, donor10252	10163-103B1	89.10	11.81	1.34
occipital cortex, newborn, donor10223	10355-105E4	67.69	8.01	1.09
occipital lobe, adult, donor1	10076-102A4	33.06	2.89	1.31
occipital lobe, fetal, donor1	10073-102A1	65.22	4.29	7.29
occipital pole, adult, pool1	10036-101E9	35.56	3.31	0.87
olfactory region, adult	10195-103E6	49.86	5.35	1.15
optic nerve, donor1	10277-104E7	30.02	4.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	62.76	11.85	0.46
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	49.60	2.20	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	58.76	12.70	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	46.20	7.51	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	62.91	7.35	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	38.31	5.61	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	37.53	5.94	0.42
ovary, adult, pool1	10020-101D2	69.79	14.24	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	64.90	6.60	0.73
pancreas, adult, donor1	10049-101G4	32.92	7.53	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	21.52	1.68	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	29.98	8.69	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	89.41	15.73	1.82
paracentral gyrus, adult, pool1	10035-101E8	32.31	3.11	1.01
parietal cortex, adult, donor10258	10373-105G4	28.63	4.40	1.47
parietal lobe - adult, donor10196	10171-103B9	53.61	9.40	2.82
parietal lobe, adult, donor10252	10157-103A4	80.10	7.70	2.85
parietal lobe, adult, pool1	10034-101E7	38.60	4.14	0.97
parietal lobe, fetal, donor1	10072-101I9	79.53	1.94	8.73
parietal lobe, newborn, donor10223	10356-105E5	77.02	8.97	0.00
parotid gland, adult	10199-103F1	48.10	9.25	0.00
penis, adult	10200-103F2	92.38	22.56	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	28.26	0.00	3.72
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	99.36	23.46	0.73
pineal gland - adult, donor10196	10179-103C8	63.21	5.16	1.29
pineal gland, adult, donor10252	10160-103A7	69.88	5.33	0.00
pineal gland, adult, donor10258	10377-105G8	56.44	4.39	0.63
pituitary gland - adult, donor10196	10180-103C9	76.90	9.11	1.01
pituitary gland, adult, donor10252	10162-103A9	110.49	13.55	2.61
pituitary gland, adult, donor10258	10378-105G9	79.17	6.81	2.55
placenta, adult, pool1	10021-101D3	52.68	9.46	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	74.82	16.42	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	86.07	17.43	0.16
pons, adult, pool1	10033-101E6	30.04	4.30	0.34
postcentral gyrus, adult, pool1	10032-101E5	36.09	3.49	0.61
promyelocytes/myelocytes PMC, donor1	12132-128D8	106.66	14.64	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	77.11	5.51	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	38.60	6.41	0.15
prostate cancer cell line:PC-3	10439-106E7	36.84	5.63	0.36
prostate, adult, pool1	10022-101D4	69.83	13.24	0.36
putamen, adult, donor10196	10176-103C5	59.02	12.98	2.36
putamen, adult, donor10252	10152-102I8	41.18	5.88	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	33.88	0.00	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	32.38	3.87	1.69
putamen, newborn, donor10223	10365-105F5	65.97	1.50	0.00
rectal cancer cell line:TT1TKB	10469-106I1	27.64	3.49	0.00
rectum, fetal, donor1	10067-101I4	83.46	12.52	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	82.68	8.90	1.27
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	115.15	17.81	4.97
retina, adult, pool1	10030-101E3	68.29	12.13	1.39
retinoblastoma cell line:Y79	10475-106I7	38.45	3.64	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	41.56	9.10	0.61
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	22.50	1.12	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	70.48	13.64	0.00
salivary acinar cells, donor1	11771-123I7	91.93	8.58	0.65
salivary acinar cells, donor2	11772-123I8	122.82	11.01	0.41
salivary acinar cells, donor3	11773-123I9	113.21	11.25	0.00
salivary gland, adult, pool1	10093-102C3	109.24	3.43	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	58.51	9.78	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	55.01	8.82	0.35
seminal vesicle, adult	10201-103F3	117.45	7.94	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	46.16	9.96	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	62.66	14.59	1.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	78.28	6.02	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	27.67	1.88	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	28.07	6.74	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	35.35	3.35	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	70.22	7.80	0.71
skeletal muscle, adult, pool1	10023-101D5	46.18	11.63	0.60
skeletal muscle, fetal, donor1	10066-101I3	70.35	8.04	1.01
skin, adult, donor1	10074-102A2	27.14	6.79	0.00
skin, fetal, donor1	10065-101I2	102.26	14.52	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	23.35	2.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	40.35	1.58	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	42.02	0.77	1.16
small cell lung carcinoma cell line:LK-2	10541-107H1	29.67	0.99	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	61.44	0.64	2.90
small cell lung carcinoma cell line:WA-hT	10562-108A4	42.93	24.19	0.22
small intestine, adult, pool1	10024-101D6	62.11	15.53	0.36
small intestine, fetal, donor1	10064-101I1	46.44	12.78	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	39.49	3.08	0.00
smooth muscle, adult, pool1	10048-101G3	63.06	11.63	0.52
somatostatinoma cell line:QGP-1	10781-110G7	19.30	0.80	0.00
spinal cord - adult, donor10196	10181-103D1	74.33	13.53	0.92
spinal cord, adult, donor10252	10159-103A6	55.20	7.89	1.97
spinal cord, adult, donor10258	10369-105F9	38.05	2.77	2.08
spinal cord, fetal, donor1	10056-101H2	35.98	6.71	0.00
spinal cord, newborn, donor10223	10359-105E8	67.96	6.89	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	49.44	4.48	0.45
spleen, adult, pool1	10025-101D7	74.23	17.40	0.55
spleen, fetal, pool1	10044-101F8	86.84	20.90	0.40
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	61.80	20.81	0.72
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	36.08	6.65	0.95
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	23.76	4.89	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	77.40	10.56	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	48.96	10.02	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	73.71	3.81	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	50.77	7.62	0.00
stomach, fetal, donor1	10062-101H8	89.71	17.09	0.00
submaxillary gland, adult	10202-103F4	104.82	11.39	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	58.57	7.06	0.42
substantia nigra, adult, donor10258	10371-105G2	34.14	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	57.94	3.53	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	42.41	2.29	0.92
temporal lobe, adult, pool1	10031-101E4	38.99	4.66	0.76
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	76.21	6.41	3.56
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	64.17	4.40	3.08
tenocyte, donor1	11763-123H8	115.20	20.25	1.05
tenocyte, donor2	11765-123I1	69.05	13.73	0.00
tenocyte, donor3	11768-123I4	69.69	5.93	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	54.22	5.78	0.68
teratocarcinoma cell line:NCR-G1	10798-110I6	24.66	3.39	0.15
teratocarcinoma cell line:PA-1	10807-111A6	32.70	2.17	0.77
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	18.03	2.92	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	42.73	1.89	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	37.63	1.42	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	80.77	3.26	0.33
testis, adult, pool1	10026-101D8	55.73	7.95	0.97
testis, adult, pool2	10096-102C6	49.17	5.41	3.16
thalamus - adult, donor10196	10168-103B6	79.49	4.42	0.00
thalamus, adult, donor10252	10154-103A1	65.95	9.06	1.56
thalamus, adult, donor10258, tech_rep1	10370-105G1	46.19	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	24.21	0.82	0.66
thalamus, newborn, donor10223	10366-105F6	47.18	1.73	0.00
throat, adult	10209-103G2	56.43	9.24	1.00
throat, fetal, donor1	10061-101H7	78.92	9.75	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	61.01	5.17	1.39
thymus, adult, pool1	10027-101D9	99.32	11.04	5.96
thymus, fetal, pool1	10043-101F7	114.09	15.90	3.74
thyroid carcinoma cell line:KHM-5M	10776-110G2	88.42	7.58	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	73.90	16.62	1.40
thyroid, adult, pool1	10028-101E1	69.52	14.37	0.84
thyroid, fetal, donor1	10060-101H6	86.48	10.81	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	190.94	9.24	0.00
tongue, adult	10203-103F5	76.05	11.63	0.47
tongue, fetal, donor1	10059-101H5	47.69	7.49	0.39
tonsil, adult, pool1	10047-101G2	97.47	21.84	1.30
trachea, adult, pool1	10029-101E2	74.76	13.74	0.33
trachea, fetal, donor1	10058-101H4	57.32	11.93	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	47.47	11.34	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	77.00	13.88	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	51.24	12.22	1.25
tridermal teratoma cell line:HGRT	10694-109G1	24.73	7.61	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	32.42	5.84	0.25
umbilical cord, fetal, donor1	10057-101H3	43.82	8.35	2.09
uterus, adult, pool1	10100-102D1	144.52	15.70	0.68
uterus, fetal, donor1	10055-101H1	85.49	9.73	1.02
vagina, adult	10204-103F6	124.72	7.75	0.65
vein, adult	10191-103E2	106.31	17.97	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	98.54	23.23	0.80